Dermata Therapeutics, Inc. Gains 50.78%
Thu, Feb 19, 2026 at 07:32 PM
Dermata Therapeutics, Inc. (DRMA:NASDAQ) shot up at $1.93, representing a gain of 50.8%. On Thu, Feb 19, 2026, DRMA:NASDAQ touched a New 2-Week High of $1.93. The stock got featured on our News Catalysts scanner on Sat, Feb 07, 2026 at 01:03 AM in the 'MISCELLANEOUS' category. From Thu, Feb 05, 2026, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Mon, Jan 26, 2026 at $4.66 with a volume of 27M+.
About Dermata Therapeutics, Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- KNOREX LTD. Class A (KNRX:NYSEMKT), 165.32%
- Dermata Therapeutics, Inc. (DRMA:NASDAQ), 50.78%
- Namib Minerals (NAMM:NASDAQ), 37.12%
- Battalion Oil Corporation (BATL:NYSEMKT), 35.41%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 34.15%
- Cardinal Infrastructure Group Inc. (CDNL:NASDAQ), 31.31%
- C3is Inc. (CISS:NASDAQ), 31.14%
- Allied Gaming & Entertainment Inc. (AGAE:NASDAQ), 27.1%
- One Stop Systems, Inc. (OSS:NASDAQ), 26.23%
- UTime Limited (WTO:NASDAQ), 26.14%